MARÍA DOLORES
CABALLERO BARRIGÓN
Ikertzailea 1998-2022 tartean
University of Texas Health Science Center at San Antonio
San Antonio, Estados UnidosUniversity of Texas Health Science Center at San Antonio-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2012
-
Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy
Journal of Clinical Oncology, Vol. 30, Núm. 6, pp. 631-636